Literature DB >> 10452545

Persistence of botulinum neurotoxin action in cultured spinal cord cells.

J E Keller1, E A Neale, G Oyler, M Adler.   

Abstract

Primary dissociated fetal mouse spinal cord cultures were used to study the mechanisms underlying the differences in persistence of botulinum neurotoxin A (BoNT/A) and botulinum neurotoxin/E (BoNT/E) activities. Spinal cord cultures were exposed to BoNT/A (0.4 pM) for 2-3 days, which converted approximately half of the SNAP-25 to an altered form lacking the final nine C-terminal residues. The distribution of toxin-damaged to control SNAP-25 remained relatively unchanged for up to 80 days thereafter. Application of a high concentration of BoNT/E (250 pM) either 25 or 60 days following initial intoxication with BoNT/A converted both normal and BoNT/A-truncated SNAP-25 into a single population lacking the final 26 C-terminal residues. Excess BoNT/E was removed by washout, and recovery of intact SNAP-25 was monitored by Western blot analysis. The BoNT/E-truncated species gradually diminished during the ensuing 18 days, accompanied by the reappearance of both normal and BoNT/A-truncated SNAP-25. Return of BoNT/A-truncated SNAP-25 was observed in spite of the absence of BoNT/A in the culture medium during all but the first 3 days of exposure. These results indicate that proteolytic activity associated with the BoNT/A light chain persists inside cells for > 11 weeks, while recovery from BoNT/E is complete in < 3 weeks. This longer duration of enzymatic activity appears to account for the persistence of serotype A action.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10452545     DOI: 10.1016/s0014-5793(99)00948-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  56 in total

1.  Neurotransmitter vesicle release from human model neurons (NT2) is sensitive to botulinum toxin A.

Authors:  Million Adane Tegenge; Helge Böhnel; Frank Gessler; Gerd Bicker
Journal:  Cell Mol Neurobiol       Date:  2012-02-29       Impact factor: 5.046

Review 2.  Botulinum neurotoxin structure, engineering, and novel cellular trafficking and targeting.

Authors:  B R Singh
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

3.  Comparison of extracellular and intracellular potency of botulinum neurotoxins.

Authors:  Fang Cai; Carrie B Adrion; James E Keller
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

4.  An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonists.

Authors:  Lisa M Eubanks; Mark S Hixon; Wei Jin; Sukwon Hong; Colin M Clancy; William H Tepp; Michael R Baldwin; Carl J Malizio; Michael C Goodnough; Joseph T Barbieri; Eric A Johnson; Dale L Boger; Tobin J Dickerson; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-09       Impact factor: 11.205

5.  A neuronal cell-based botulinum neurotoxin assay for highly sensitive and specific detection of neutralizing serum antibodies.

Authors:  Sabine Pellett; William H Tepp; Colin M Clancy; Gary E Borodic; Eric A Johnson
Journal:  FEBS Lett       Date:  2007-09-12       Impact factor: 4.124

Review 6.  The blockade of the neurotransmitter release apparatus by botulinum neurotoxins.

Authors:  Sergio Pantano; Cesare Montecucco
Journal:  Cell Mol Life Sci       Date:  2013-06-11       Impact factor: 9.261

7.  Covalent Modifiers of Botulinum Neurotoxin Counteract Toxin Persistence.

Authors:  Megan Garland; Brett M Babin; Shin-Ichiro Miyashita; Sebastian Loscher; Yi Shen; Min Dong; Matthew Bogyo
Journal:  ACS Chem Biol       Date:  2019-01-08       Impact factor: 5.100

Review 8.  Therapeutic use of botulinum toxin in migraine: mechanisms of action.

Authors:  Roshni Ramachandran; Tony L Yaksh
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

9.  Botulinum and Tetanus Neurotoxin-Induced Blockade of Synaptic Transmission in Networked Cultures of Human and Rodent Neurons.

Authors:  Phillip H Beske; Aaron B Bradford; Justin O Grynovicki; Elliot J Glotfelty; Katie M Hoffman; Kyle S Hubbard; Kaylie M Tuznik; Patrick M McNutt
Journal:  Toxicol Sci       Date:  2015-11-28       Impact factor: 4.849

10.  Botulinum Toxin: Non-cosmetic Indications and Possible Mechanisms of Action.

Authors:  Uwe Wollina
Journal:  J Cutan Aesthet Surg       Date:  2008-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.